Cambio

Executive Summary

Cambio is a Cambridge, UK-based supplier of molecular biology products, established in 1993. The company offers a comprehensive range of cutting-edge reagents and tools for discerning molecular biologists, aiming to simplify and enhance research workflows. As a private entity with a long operating history, Cambio has built a reputation for flexibility and product breadth in the life sciences tools market. While the company does not disclose financials or have publicly listed pipelines, its sustained presence suggests a stable niche in the diagnostics and digital health supply chain. Cambio's focus on customer-centric product offerings positions it as a reliable partner for academic and commercial laboratories requiring specialized molecular biology consumables and equipment.

Upcoming Catalysts (preview)

• Q3 2026Launch of new next-generation sequencing (NGS) library preparation kits60% success
• TBDExpansion of direct-to-consumer sales channels or partnerships with major distributors50% success
• TBDPotential acquisition by a larger life sciences tools company seeking to broaden product catalog20% success